Bristol-Myers Squibb to acquire cancer treatments developer Wyeth reports mixed results for Q2 Eli Lilly, Amylin announce clinical trial results of exenatide Dr. Reddy’s announces unaudited Q1 results Nycomed awaits pending FDA approval for COPD treatment ImClone, BMS revise U.S. prescribing info of cancer drug Human Genome Sciences, GSK announce trial results for systemic lupus treatment Gilead enters partnership with Tibotec to develop HIV drug Asthma medication under fire by the FDA amid study findings Fera Pharmaceuticals acquires portfolio of ophthalmic ointments First Previous 233 234 235 236 237 Next Last